SciELO - Scientific Electronic Library Online

 
vol.33 número2Síntesis biológica de nanopartículas de plata: revisión del uso potencial de la especie Trichoderma índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista Cubana de Química

versão On-line ISSN 2224-5421

Resumo

RODRIGUEZ-IZQUIERDO, Julio Ricardo et al. Nanoparticles of Gd2O3 pegylated and conjugated to amylovis with potential application in the detection of alzheimer by MRI. Rev Cub Quim [online]. 2021, vol.33, n.2, pp. 3-22.  Epub 26-Abr-2021. ISSN 2224-5421.

Specific contrast agents facilitate the use of Magnetic Resonance Imaging (MRI) in the early diagnosis of Alzheimer's disease (AD). In the present work, a procedure for the synthesis of a potential MRI contrast agent based on PEGylated Gd2O3 particles is developed for conjugation to Amylovis®, a family of compounds that has shown a high affinity for the pathological structures present in AD. The products obtained were characterized by FT-IR, ICP, TGA, DLS and SEM. Amylovis-functionalized Gd2O3 particles showed a spherical morphology, with an average hydrodynamic diameter of 2.5 μm. These particles presented an adequate value of the ratio between the longitudinal (r1) and transversal (r2) relaxivities (r2/r1 = 2.4). This suggests that once these particles have a hydrodynamic diameter smaller than 200 nm, they could be used as a potential contrast agent for MRI.

Palavras-chave : alzheimer disease; contrast agent; nanoparticles; gadolinium oxide; MRI.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )